ArticleMolecular cancer therapeutics2018

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

Yan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.